For HIDS patients, MVK enzyme activity is reduced until 1-10%, while it is reduced to less than 1% in MEVA, which is characterized by serious neurological impairment, failure to thrive, and early death, in addition to HIDS manifestations [118]. This evidence concerns the gene MVK and mevalonic aciduria.